The relationship between COVID-19 anxiety and self-efficacy among adolescent students: A cross-sectional study.

Publication date: Dec 05, 2024

The spread of the COVID-19 epidemic, as well as its high contagiousness, increased students’ anxiety and stress. Anxiety may affect individuals’ functioning and undermine their self-efficacy. Therefore, the present study aimed to determine the relationship between COVID-19 anxiety and self-efficacy among adolescent students. This cross-sectional descriptive correlational study was conducted on 306 adolescent students in southern Iran. The research tools were the Corona Disease Anxiety Scale consisting of physical and psychological dimensions of anxiety and the Self-Efficacy Scale composed of three subscales: academic, social, and emotional self-efficacy. Data were analyzed using SPSS 25. Pearson correlation was used to investigate the relationship between COVID-19 anxiety and self-efficacy using the total score of both scales and their dimensions as well. T-Test and one-way ANOVA were used to see whether sociodemographic variables of participants significantly varied in self-efficacy and COVID-19 anxiety. The mean score of COVID-19 anxiety was 11. 70 +/- 9. 25, representing mild anxiety, and the mean score of the psychological dimension was higher than that of the physical dimension. The mean self-efficacy score was 81. 29 +/- 12. 98 indicating high level of self-efficacy. In addition, the mean score of academic self-efficacy was higher than that of social and emotional self-efficacy. There was an inverse, significant, and mild to moderate relationship between COVID-19 anxiety and the total score of self-efficacy (r = -. 28, p < .001) and all its dimensions (r = -. 18, p = .002 for social and academic self-efficacy; r = -. 32, p

Open Access PDF

Concepts Keywords
Academic Adolescent
Covid Anxiety
Increased COVID-19
Iran Cross-Sectional Studies
Psychological Female
Humans
Iran
Male
SARS-CoV-2
Self Efficacy
Students
Surveys and Questionnaires

Semantics

Type Source Name
disease MESH COVID-19
disease MESH anxiety
disease IDO contagiousness
disease MESH Long Covid
drug DRUGBANK Rasagiline
pathway REACTOME Reproduction
drug DRUGBANK Adenosine
drug DRUGBANK Spinosad
disease MESH viral diseases
disease IDO virulence
disease IDO country
disease MESH morbidity
disease MESH cognitive impairments
pathway REACTOME Immune System
disease IDO susceptibility
disease MESH death
disease MESH depression
drug DRUGBANK Trestolone
disease IDO history
disease MESH psychosis
disease MESH separation anxiety
disease MESH panic disorder
disease MESH mental disorder
disease MESH education level
drug DRUGBANK Ranitidine
disease MESH chronic illness
pathway KEGG Coronavirus disease
disease MESH social anxiety disorder
disease MESH sti
disease MESH infection
disease MESH complications
disease MESH Emerging infectious diseases
disease MESH psychological well being
drug DRUGBANK Etoperidone
disease MESH PTSD
drug DRUGBANK Trihexyphenidyl
drug DRUGBANK Methylergometrine

Original Article

(Visited 1 times, 1 visits today)